Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells

Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (T ) suppress immune cells within close proximity by activating latent TGF-β1 presen...

Full description

Saved in:
Bibliographic Details
Published inScience (American Association for the Advancement of Science) Vol. 362; no. 6417; pp. 952 - 956
Main Authors Liénart, Stéphanie, Merceron, Romain, Vanderaa, Christophe, Lambert, Fanny, Colau, Didier, Stockis, Julie, van der Woning, Bas, De Haard, Hans, Saunders, Michael, Coulie, Pierre G, Savvides, Savvas N, Lucas, Sophie
Format Journal Article
LanguageEnglish
Published United States The American Association for the Advancement of Science 23.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (T ) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by T .
AbstractList Visualizing TGF-β1 regulation by GARPRegulatory T cells (Tregs) can suppress immune responses through a variety of mechanisms. One such mechanism involves the activation of a surface-bound latent form of the cytokine transforming growth factor–β1 (TGF-β1). Within the cell, newly synthesized pro-TGF-β1 homodimers form disulfide bonds with the transmembrane protein GARP, which acts to chaperone and orient the cytokine for activation at the cell surface. Liénart et al. reveal how GARP interacts with TGF-β1, using a crystal structure in which the complex was stabilized using a Fab fragment from a monoclonal antibody (MHG-8) that binds to the complex. In so doing, they also demonstrate how MHG-8 prevents membrane-associated TGF-β1 release. These structural and mechanistic insights may inform treatments of diseases with altered TGF-β1 functionality and dysfunctional Treg activity, including cancer immunotherapy.Science, this issue p. 952Transforming growth factor–β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (Tregs) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by Tregs.
Visualizing TGF-β1 regulation by GARP Regulatory T cells (T regs ) can suppress immune responses through a variety of mechanisms. One such mechanism involves the activation of a surface-bound latent form of the cytokine transforming growth factor–β1 (TGF-β1). Within the cell, newly synthesized pro-TGF-β1 homodimers form disulfide bonds with the transmembrane protein GARP, which acts to chaperone and orient the cytokine for activation at the cell surface. Liénart et al. reveal how GARP interacts with TGF-β1, using a crystal structure in which the complex was stabilized using a Fab fragment from a monoclonal antibody (MHG-8) that binds to the complex. In so doing, they also demonstrate how MHG-8 prevents membrane-associated TGF-β1 release. These structural and mechanistic insights may inform treatments of diseases with altered TGF-β1 functionality and dysfunctional T reg activity, including cancer immunotherapy. Science , this issue p. 952 A crystal structure elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by regulatory T cells. Transforming growth factor–β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (T regs ) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by T regs .
Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (T ) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by T .
Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects on development, immunity, and cancer. Regulatory T cells (Tregs) suppress immune cells within close proximity by activating latent TGF-β1 presented by GARP (glycoprotein A repetitions predominant) to integrin αVβ8 on their surface. We solved the crystal structure of GARP:latent TGF-β1 bound to an antibody that stabilizes the complex and blocks release of active TGF-β1. This finding reveals how GARP exploits an unusual medley of interactions, including fold complementation by the amino terminus of TGF-β1, to chaperone and orient the cytokine for binding and activation by αVβ8. Thus, this work further elucidates the mechanism of antibody-mediated blockade of TGF-β1 activation and immunosuppression by Tregs.
Author Lambert, Fanny
van der Woning, Bas
Saunders, Michael
Lucas, Sophie
Vanderaa, Christophe
Stockis, Julie
Coulie, Pierre G
Liénart, Stéphanie
Merceron, Romain
Savvides, Savvas N
Colau, Didier
De Haard, Hans
Author_xml – sequence: 1
  givenname: Stéphanie
  orcidid: 0000-0002-5825-6979
  surname: Liénart
  fullname: Liénart, Stéphanie
  organization: de Duve Institute, UCLouvain, 1200 Brussels, Belgium
– sequence: 2
  givenname: Romain
  surname: Merceron
  fullname: Merceron, Romain
  organization: VIB Center for Inflammation Research, 9052 Ghent, Belgium
– sequence: 3
  givenname: Christophe
  orcidid: 0000-0001-7443-5427
  surname: Vanderaa
  fullname: Vanderaa, Christophe
  organization: de Duve Institute, UCLouvain, 1200 Brussels, Belgium
– sequence: 4
  givenname: Fanny
  surname: Lambert
  fullname: Lambert, Fanny
  organization: de Duve Institute, UCLouvain, 1200 Brussels, Belgium
– sequence: 5
  givenname: Didier
  surname: Colau
  fullname: Colau, Didier
  organization: Ludwig Cancer Research, Brussels, Belgium
– sequence: 6
  givenname: Julie
  orcidid: 0000-0003-4911-6891
  surname: Stockis
  fullname: Stockis, Julie
  organization: Walloon Excellence in Lifesciences and Biotechnology, 1300 Wavre, Belgium
– sequence: 7
  givenname: Bas
  surname: van der Woning
  fullname: van der Woning, Bas
  organization: argenx, 9052 Zwijnaarde, Belgium
– sequence: 8
  givenname: Hans
  surname: De Haard
  fullname: De Haard, Hans
  organization: argenx, 9052 Zwijnaarde, Belgium
– sequence: 9
  givenname: Michael
  surname: Saunders
  fullname: Saunders, Michael
  organization: argenx, 9052 Zwijnaarde, Belgium
– sequence: 10
  givenname: Pierre G
  surname: Coulie
  fullname: Coulie, Pierre G
  organization: Walloon Excellence in Lifesciences and Biotechnology, 1300 Wavre, Belgium
– sequence: 11
  givenname: Savvas N
  orcidid: 0000-0003-3420-5947
  surname: Savvides
  fullname: Savvides, Savvas N
  email: sophie.lucas@uclouvain.be, savvas.savvides@ugent.be
  organization: VIB Center for Inflammation Research, 9052 Ghent, Belgium
– sequence: 12
  givenname: Sophie
  orcidid: 0000-0003-1287-7996
  surname: Lucas
  fullname: Lucas, Sophie
  email: sophie.lucas@uclouvain.be, savvas.savvides@ugent.be
  organization: Walloon Excellence in Lifesciences and Biotechnology, 1300 Wavre, Belgium
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30361387$$D View this record in MEDLINE/PubMed
BookMark eNpdkM1KAzEQgINUtFbP3iTgxcvqJHF_cixFqyAoWs_LbHZWV7bZmmyEvpYP4jMZafXgaWaYb374DtjI9pYYOxZwLoTMLrxpyRo6RwxSg95hYwE6TbQENWJjAJUlBeTpPjvw_g0g9rTaY_sqNoQq8jGrngYXzBAcdrxC33reN7zDgezAF_Pr5OtT8JUjH2sc2t5ytDVHM7Qfm7Ja8_n08YHH9DUs0XJHLyHO927NF9xQ1_lDtttg5-loGyfs-fpqMbtJ7u7nt7PpXWJkIXSSS9EYgipVJBRBU0lUhchEVjSVuqyglijzvK6laYAUihpTJdDUmlJKQVyqCTvb7F25_j2QH8pl638-QEt98KWMwrQACTqip__Qtz44G7-LVLxaZEpnkbrYUMb13jtqypVrl-jWpYDyR3-51V9u9ceJk-3eUC2p_uN_fatvmqiExQ
CitedBy_id crossref_primary_10_1016_j_jhep_2023_05_043
crossref_primary_10_1186_s12967_023_03943_9
crossref_primary_10_1158_0008_5472_CAN_18_2623
crossref_primary_10_1186_s13601_020_00347_6
crossref_primary_10_1097_TXD_0000000000001475
crossref_primary_10_1126_sciimmunol_abi4613
crossref_primary_10_1016_j_tcb_2019_10_002
crossref_primary_10_1007_s00262_021_03119_8
crossref_primary_10_1111_wrr_12950
crossref_primary_10_3390_cancers12113099
crossref_primary_10_1038_s41598_019_44943_4
crossref_primary_10_1002_sctm_19_0372
crossref_primary_10_1038_s41392_021_00769_z
crossref_primary_10_1007_s12079_021_00616_4
crossref_primary_10_3390_cancers11091221
crossref_primary_10_3389_fped_2022_859034
crossref_primary_10_1016_j_mbplus_2024_100149
crossref_primary_10_1007_s10585_021_10077_z
crossref_primary_10_1016_j_immuni_2019_03_024
crossref_primary_10_3389_fcell_2021_678524
crossref_primary_10_1126_scisignal_aav5183
crossref_primary_10_3390_biom10030487
crossref_primary_10_1038_s41431_019_0411_8
crossref_primary_10_1038_s41423_021_00701_z
crossref_primary_10_1136_jitc_2022_005433
crossref_primary_10_1038_s41580_024_00716_0
crossref_primary_10_3389_fphar_2021_770884
crossref_primary_10_1038_s41467_020_17811_3
crossref_primary_10_1038_s41586_022_05089_y
crossref_primary_10_1136_jitc_2020_001798
crossref_primary_10_1016_j_it_2020_07_003
crossref_primary_10_1016_j_gendis_2022_10_019
crossref_primary_10_1186_s12943_020_01234_1
crossref_primary_10_1038_s41392_020_00436_9
crossref_primary_10_3390_v14102146
crossref_primary_10_1016_j_cell_2019_12_030
crossref_primary_10_1007_s00262_021_03104_1
crossref_primary_10_1038_s41571_020_0403_1
crossref_primary_10_3389_fcell_2021_742088
crossref_primary_10_1016_j_pharmthera_2019_107399
crossref_primary_10_1016_j_semcdb_2019_12_010
crossref_primary_10_1182_blood_2022017097
crossref_primary_10_1126_sciimmunol_abf0558
crossref_primary_10_1172_JCI139905
crossref_primary_10_1182_blood_2022015474
crossref_primary_10_1016_j_lfs_2021_119359
crossref_primary_10_1126_scisignal_adn6052
crossref_primary_10_1177_1535370219880894
crossref_primary_10_3389_fimmu_2020_00723
crossref_primary_10_1016_j_ccell_2023_05_016
crossref_primary_10_1186_s40779_022_00414_y
crossref_primary_10_1038_s41467_022_32655_9
crossref_primary_10_1042_BST20200663
crossref_primary_10_1038_s41467_021_24213_6
crossref_primary_10_1186_s12931_022_02099_2
crossref_primary_10_1016_j_jcyt_2019_10_011
crossref_primary_10_3389_fimmu_2021_704050
crossref_primary_10_2147_JIR_S308963
crossref_primary_10_1128_mbio_00199_24
crossref_primary_10_3390_biology10090836
crossref_primary_10_3389_fimmu_2020_610963
crossref_primary_10_1038_s41568_021_00413_6
crossref_primary_10_4049_immunohorizons_2200072
crossref_primary_10_1111_imcb_12479
crossref_primary_10_1016_j_pharmthera_2023_108528
crossref_primary_10_1126_scitranslmed_aaz3866
crossref_primary_10_1016_j_bcp_2021_114697
crossref_primary_10_1016_j_jhep_2024_01_005
crossref_primary_10_3389_fonc_2024_1362247
crossref_primary_10_1093_intimm_dxab027
crossref_primary_10_1016_j_bbadis_2024_167230
crossref_primary_10_1136_jitc_2020_002044
crossref_primary_10_1080_14728222_2019_1636034
crossref_primary_10_1136_jitc_2020_001478
crossref_primary_10_1016_j_ijporl_2021_110709
crossref_primary_10_3389_fimmu_2022_928450
crossref_primary_10_1016_j_matbio_2022_08_001
crossref_primary_10_1007_s12032_022_01881_y
crossref_primary_10_1155_2023_8848808
crossref_primary_10_1016_j_immuni_2020_10_002
crossref_primary_10_3390_cancers15235621
crossref_primary_10_1021_acs_biomac_0c00264
crossref_primary_10_1073_pnas_2304874120
crossref_primary_10_1038_s41571_024_00870_6
crossref_primary_10_1107_S205225251901707X
crossref_primary_10_3389_fimmu_2019_00680
crossref_primary_10_3389_fimmu_2022_942468
crossref_primary_10_1093_g3journal_jkac271
crossref_primary_10_1242_jcs_239434
crossref_primary_10_1016_j_jmb_2021_167439
crossref_primary_10_1126_scitranslmed_aay4860
crossref_primary_10_3389_fcell_2021_764727
crossref_primary_10_1002_dvdy_339
crossref_primary_10_1158_2326_6066_CIR_21_0593
crossref_primary_10_1016_j_ajhg_2020_02_014
crossref_primary_10_1038_s41467_021_26352_2
crossref_primary_10_1007_s00018_021_03873_z
Cites_doi 10.1016/j.sbi.2015.02.001
10.1039/C7MB00251C
10.1038/nature21035
10.1016/j.cell.2018.05.027
10.1073/pnas.0901944106
10.1146/annurev-immunol-032713-120257
10.1038/nsb0497-269
10.1073/pnas.1710680114
10.1126/scitranslmed.aaa1983
10.1002/eji.200939684
10.1038/nature10152
10.1073/pnas.1000093107
10.1101/cshperspect.a021907
10.1107/S0021889897003907
10.1016/j.cytogfr.2013.06.003
10.1101/cshperspect.a022103
10.1016/j.sbi.2014.05.007
10.1016/j.coi.2013.12.005
10.1091/mbc.e11-12-1018
10.1107/S0907444909042073
10.1371/journal.pone.0076186
10.1074/jbc.M117.797613
10.1126/science.1218231
10.1038/s41580-018-0007-0
ContentType Journal Article
Copyright Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
Copyright_xml – notice: Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
– notice: Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QF
7QG
7QL
7QP
7QQ
7QR
7SC
7SE
7SN
7SP
7SR
7SS
7T7
7TA
7TB
7TK
7TM
7U5
7U9
8BQ
8FD
C1K
F28
FR3
H8D
H8G
H94
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
M7N
P64
RC3
7X8
DOI 10.1126/science.aau2909
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Aluminium Industry Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Ceramic Abstracts
Chemoreception Abstracts
Computer and Information Systems Abstracts
Corrosion Abstracts
Ecology Abstracts
Electronics & Communications Abstracts
Engineered Materials Abstracts
Entomology Abstracts (Full archive)
Industrial and Applied Microbiology Abstracts (Microbiology A)
Materials Business File
Mechanical & Transportation Engineering Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Solid State and Superconductivity Abstracts
Virology and AIDS Abstracts
METADEX
Technology Research Database
Environmental Sciences and Pollution Management
ANTE: Abstracts in New Technology & Engineering
Engineering Research Database
Aerospace Database
Copper Technical Reference Library
AIDS and Cancer Research Abstracts
Materials Research Database
ProQuest Computer Science Collection
ProQuest Health & Medical Complete (Alumni)
Civil Engineering Abstracts
Advanced Technologies Database with Aerospace
Computer and Information Systems Abstracts – Academic
Computer and Information Systems Abstracts Professional
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Materials Research Database
Technology Research Database
Computer and Information Systems Abstracts – Academic
Mechanical & Transportation Engineering Abstracts
Nucleic Acids Abstracts
ProQuest Computer Science Collection
Computer and Information Systems Abstracts
ProQuest Health & Medical Complete (Alumni)
Materials Business File
Environmental Sciences and Pollution Management
Aerospace Database
Copper Technical Reference Library
Engineered Materials Abstracts
Genetics Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Advanced Technologies Database with Aerospace
ANTE: Abstracts in New Technology & Engineering
Civil Engineering Abstracts
Aluminium Industry Abstracts
Virology and AIDS Abstracts
Electronics & Communications Abstracts
Ceramic Abstracts
Ecology Abstracts
Neurosciences Abstracts
METADEX
Biotechnology and BioEngineering Abstracts
Computer and Information Systems Abstracts Professional
Entomology Abstracts
Animal Behavior Abstracts
Solid State and Superconductivity Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Corrosion Abstracts
MEDLINE - Academic
DatabaseTitleList Materials Research Database
CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Biology
EISSN 1095-9203
EndPage 956
ExternalDocumentID 10_1126_science_aau2909
30361387
Genre Journal Article
GroupedDBID ---
--Z
-DZ
-ET
-~X
.-4
..I
.55
.DC
08G
0B8
0R~
0WA
123
18M
2FS
2KS
2WC
34G
36B
39C
3R3
53G
5RE
66.
6OB
6TJ
7X2
7~K
85S
8F7
AABCJ
AACGO
AAIKC
AAMNW
AANCE
AAWTO
ABCQX
ABDBF
ABDEX
ABEFU
ABIVO
ABOCM
ABPLY
ABPPZ
ABQIJ
ABTLG
ABWJO
ABXSQ
ABZEH
ACBEA
ACBEC
ACGFO
ACGFS
ACGOD
ACIWK
ACMJI
ACNCT
ACPRK
ACQOY
ADDRP
ADMHC
ADUKH
AEGBM
AENEX
AEUPB
AFFDN
AFFNX
AFHKK
AFQFN
AFRAH
AFRQD
AGFXO
AGNAY
AGSOS
AHMBA
AIDAL
AIDUJ
AJGZS
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
B-7
BKF
BLC
C45
C51
CGR
CS3
CUY
CVF
DB2
DU5
EBS
ECM
EIF
EJD
EMOBN
ESX
F5P
FA8
FEDTE
GX1
HZ~
I.T
IAO
IEA
IGG
IGS
IH2
IHR
INH
INR
IOF
IOV
IPO
IPY
ISE
JCF
JLS
JSG
JST
K-O
KCC
L7B
LSO
LU7
M0P
MQT
MVM
N9A
NEJ
NHB
NPM
O9-
OCB
OFXIZ
OGEVE
OK1
OMK
OVD
P-O
P2P
PQQKQ
PZZ
QS-
RHF
RHI
RXW
SC5
SJN
TAE
TEORI
TN5
TWZ
UBW
UCV
UHB
UIG
UKR
UMD
UNMZH
UQL
USG
VQA
VVN
WH7
WI4
X7M
XJF
XZL
Y6R
YCJ
YK4
YKV
YNT
YOJ
YR2
YRY
YSQ
YV5
YWH
YYP
YYQ
YZZ
ZCA
ZE2
ZKG
~02
~G0
~KM
~ZZ
AAYXX
CITATION
7QF
7QG
7QL
7QP
7QQ
7QR
7SC
7SE
7SN
7SP
7SR
7SS
7T7
7TA
7TB
7TK
7TM
7U5
7U9
8BQ
8FD
C1K
F28
FR3
H8D
H8G
H94
JG9
JQ2
K9.
KR7
L7M
L~C
L~D
M7N
P64
RC3
7X8
AETEA
AGCDD
ID FETCH-LOGICAL-c2819-721fce0b53e13e0fb2a3816168fb34b0d2a277dd2cf0e3a1da531acd9e5e50143
ISSN 0036-8075
IngestDate Sat Aug 17 03:49:04 EDT 2024
Tue Sep 24 21:21:35 EDT 2024
Thu Sep 26 17:18:43 EDT 2024
Sat Sep 28 08:32:18 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6417
Language English
License Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c2819-721fce0b53e13e0fb2a3816168fb34b0d2a277dd2cf0e3a1da531acd9e5e50143
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4911-6891
0000-0002-5825-6979
0000-0001-7443-5427
0000-0003-1287-7996
0000-0003-3420-5947
OpenAccessLink https://science.sciencemag.org/content/sci/362/6417/952.full.pdf
PMID 30361387
PQID 2138186396
PQPubID 1256
PageCount 5
ParticipantIDs proquest_miscellaneous_2126910209
proquest_journals_2138186396
crossref_primary_10_1126_science_aau2909
pubmed_primary_30361387
PublicationCentury 2000
PublicationDate 2018-Nov-23
2018-11-23
20181123
PublicationDateYYYYMMDD 2018-11-23
PublicationDate_xml – month: 11
  year: 2018
  text: 2018-Nov-23
  day: 23
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Science (American Association for the Advancement of Science)
PublicationTitleAlternate Science
PublicationYear 2018
Publisher The American Association for the Advancement of Science
Publisher_xml – name: The American Association for the Advancement of Science
References e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_20_2
e_1_3_2_10_2
e_1_3_2_21_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_22_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_23_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_24_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_25_2
References_xml – ident: e_1_3_2_21_2
  doi: 10.1016/j.sbi.2015.02.001
– ident: e_1_3_2_9_2
  doi: 10.1039/C7MB00251C
– ident: e_1_3_2_14_2
  doi: 10.1038/nature21035
– ident: e_1_3_2_16_2
  doi: 10.1016/j.cell.2018.05.027
– ident: e_1_3_2_12_2
  doi: 10.1073/pnas.0901944106
– ident: e_1_3_2_5_2
  doi: 10.1146/annurev-immunol-032713-120257
– ident: e_1_3_2_23_2
  doi: 10.1038/nsb0497-269
– ident: e_1_3_2_15_2
  doi: 10.1073/pnas.1710680114
– ident: e_1_3_2_7_2
  doi: 10.1126/scitranslmed.aaa1983
– ident: e_1_3_2_11_2
  doi: 10.1002/eji.200939684
– ident: e_1_3_2_13_2
  doi: 10.1038/nature10152
– ident: e_1_3_2_17_2
  doi: 10.1073/pnas.1000093107
– ident: e_1_3_2_20_2
  doi: 10.1101/cshperspect.a021907
– ident: e_1_3_2_24_2
  doi: 10.1107/S0021889897003907
– ident: e_1_3_2_4_2
  doi: 10.1016/j.cytogfr.2013.06.003
– ident: e_1_3_2_3_2
  doi: 10.1101/cshperspect.a022103
– ident: e_1_3_2_19_2
  doi: 10.1016/j.sbi.2014.05.007
– ident: e_1_3_2_6_2
  doi: 10.1016/j.coi.2013.12.005
– ident: e_1_3_2_10_2
  doi: 10.1091/mbc.e11-12-1018
– ident: e_1_3_2_25_2
  doi: 10.1107/S0907444909042073
– ident: e_1_3_2_8_2
  doi: 10.1371/journal.pone.0076186
– ident: e_1_3_2_18_2
  doi: 10.1074/jbc.M117.797613
– ident: e_1_3_2_22_2
  doi: 10.1126/science.1218231
– ident: e_1_3_2_2_2
  doi: 10.1038/s41580-018-0007-0
SSID ssj0009593
Score 2.6044762
Snippet Transforming growth factor-β1 (TGF-β1) is one of very few cytokines produced in a latent form, requiring activation to exert any of its vastly diverse effects...
Visualizing TGF-β1 regulation by GARP Regulatory T cells (T regs ) can suppress immune responses through a variety of mechanisms. One such mechanism involves...
Visualizing TGF-β1 regulation by GARPRegulatory T cells (Tregs) can suppress immune responses through a variety of mechanisms. One such mechanism involves the...
SourceID proquest
crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage 952
SubjectTerms Cancer
Cancer immunotherapy
Cell activation
Cell surface
Crystal structure
Cytokines
Disulfide bonds
Glycoproteins
Growth factors
Humans
Immune system
Immune Tolerance
Immunity
Immunoregulation
Immunosuppression
Immunotherapy
Lymphocyte Activation
Lymphocytes
Lymphocytes T
Medical treatment
Membrane Proteins - chemistry
Membrane Proteins - immunology
Monoclonal antibodies
Protein Conformation, beta-Strand
Protein Folding
Proteins
T-Lymphocytes, Regulatory - immunology
Transforming growth factor
Transforming Growth Factor beta1 - chemistry
Transforming Growth Factor beta1 - immunology
Transforming growth factor-b1
Title Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells
URI https://www.ncbi.nlm.nih.gov/pubmed/30361387
https://www.proquest.com/docview/2138186396/abstract/
https://search.proquest.com/docview/2126910209
Volume 362
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fb9MwELfKEBIviI1_HQMZiUlDU6bEaeLksUxbJwQIsQz1LXIcW5sE6bS2D93H4oPwzMfhznYSD6g0eInSJL2muV_uzvbd7wh5rXWcgqOLAg7BNgxQMhEILtMgkUroPFNaG-7ODx_Tk7PRu2kyHQx-ellLy0V1IK__WlfyP1qFY6BXrJL9B812QuEA7IN-YQsahu2tdHxqyF8NcQZ4I8ss8hWCx2axX0yOg93Do923LEIegLbEyKYeYzGDnYrF6HMy_vwJ1wxsu74r25wel96LfZzWn_vxa2sKIC7t1no8DXdJi2ObWtBmGrivedMO7y_sEn0jbM3Q6cJ-vjzHmvcOBph2c-UoAGbfxEUH5S-mKkeImwQJnXSBfU6MYOQnXvlzG1GGRX62_Li1144u2Xora6JD7C7Jwti34XHKPLCmI1sP6oxybjlynX_PLZH5n67Da3apDoRYsjzMey_ZZgb85jy7lEYzmGJp6QSUTsAdcpfxPMFpgck0WksH7UinvHKu9g5uxktrBkEmGCoekgduFEPHFpKbZKCaLXLP9jVdbZFNp-853XO05m8ekapHKzVopTNNLVopovXH94j6SKWgYdojlVYrikilsGuQSnuk0oIapD4mZ8dHxeFJ4Dp8BBIXcAPOIi1VWCWximIV6ooJXMiO0kxX8agKayYY53XNpA5VLKJagMsQss5Vogwz5ROy0cwa9YxQGao6kTzniZYjpqRQdZ6B8864qoXI8iHZa59jeWmJXMo1OhuSnfY5l-5tn5cswtgW4vl0SF51p8EW4_8TjZot8RqWQvjNUMRTq5_utzBUBBF8-_b38Zzc71-KHbIBWlIvIAReVC8Nmn4B8gq2Kg
link.rule.ids 315,786,790,27957,27958
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+basis+of+latent+TGF-%CE%B21+presentation+and+activation+by+GARP+on+human+regulatory+T+cells&rft.jtitle=Science+%28American+Association+for+the+Advancement+of+Science%29&rft.au=Li%C3%A9nart%2C+St%C3%A9phanie&rft.au=Merceron%2C+Romain&rft.au=Vanderaa%2C+Christophe&rft.au=Lambert%2C+Fanny&rft.date=2018-11-23&rft.issn=0036-8075&rft.eissn=1095-9203&rft.volume=362&rft.issue=6417&rft.spage=952&rft.epage=956&rft_id=info:doi/10.1126%2Fscience.aau2909&rft.externalDBID=n%2Fa&rft.externalDocID=10_1126_science_aau2909
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0036-8075&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0036-8075&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0036-8075&client=summon